Fibrolamellar carcinoma: Challenging the challenge

Detection of a Recurrent <i>DNAJB1-PRKACA</i> Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma

Joshua N. Honeyman, Elana P. Simon, Nicolas Robine et al. · Science · 2014 · 493 citations

Medicine, Genetics, Oncology +17

Phase II Trial of Systemic Continuous Fluorouracil and Subcutaneous Recombinant Interferon Alfa-2b for Treatment of Hepatocellular Carcinoma

Yehuda Z. Patt, Manal M. Hassan, Richard D. Lozano et al. · Journal of Clinical Oncology · 2003 · 198 citations

Medicine, Oncology, Pharmacotherapy +17

DNAJB1-PRKACA is specific for fibrolamellar carcinoma

Rondell P. Graham, Long Jin, Darlene L. Knutson et al. · Modern Pathology · 2015 · 183 citations · Full text

Medicine, Molecular Biology, Oncology +17

<i>DNAJB1–PRKACA</i> fusion kinase interacts with β-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma

Edward R. Kastenhuber, Gadi Lalazar, Shauna L Houlihan et al. · Proceedings of the National Academy of Sciences · 2017 · 162 citations · Full text

Medicine, Molecular Biology, Oncology +17

Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct

Aatur D. Singhi, Laura D. Wood, Michael Torbenson et al. · Gastroenterology · 2019 · 157 citations · Full text

Medicine, Oncology, Pathology +17